U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737977) titled 'Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients' on July 27.
Brief Summary: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease for which reliable biomarkers for early diagnosis, prognosis, and patient stratification remain limited. Previous genetic, proteomic, imaging, and electrophysiological studies have identified potential biomarkers and phenotype modifiers, improving the understanding of motor neuron degeneration mechanisms. However, these findings have not yet been translated into a clinically useful biomarker algorithm. This observational st...